Drug intelligence / Profile preview

autologous bone marrow-derived mesenchymal stromal cells (Royan Institute, 4c8148)

Development stage
Unknown
Lead developer
Royan Institute for Stem Cell Biology and Technology
Modality
Stem Cell Therapies → Cell Therapies
Administration
Implant, Intraarticular
01

Overview

**Autologous bone marrow-derived mesenchymal stromal cells** are a patient-specific stem cell therapy developed by Royan Institute for surgical repair of full-thickness articular cartilage defects of the knee in patients with knee osteoarthritis. In the registered Phase 1 study, the cells were transplanted in combination with a collagen type I scaffold placed at the cartilage-defect site. The intended therapeutic activity is regenerative: mesenchymal stromal cells may support cartilage repair through chondrogenic differentiation potential and local paracrine trophic and immunomodulatory signaling. This was an investigational cell-based product rather than a named, standardized commercial drug product.

Other names
autologous bone marrow mesenchymal stem cellsautologous bone marrow-derived mesenchymal stem cellsautologous bone marrow-derived MSCs

Beyond the preview

Go deeper on autologous bone marrow-derived mesenchymal stromal cells (Royan Institute, 4c8148).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on autologous bone marrow-derived mesenchymal stromal cells (Royan Institute, 4c8148).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call